Summary
Peptide-based vaccines hold great potential for immunotherapy by stimulating pathogen- or cancer-specific T cell responses. These vaccines rely on the endocytosis of antigenic peptides by dendritic cells (DCs), followed by intracellular proteolytic processing, epitope loading...